BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 35259554)

  • 1. Genomic analysis of paired IDHwt glioblastomas reveals recurrent alterations of MPDZ at relapse after radiotherapy and chemotherapy.
    Chanez B; Appay R; Guille A; Lagarde A; Colin C; Adelaide J; Denicolai E; Jiguet-Jiglaire C; Bequet C; Graillon T; Boissonneau S; Nanni-Metellus I; Dufour H; Figarella-Branger D; Chinot O; Tabouret E
    J Neurol Sci; 2022 May; 436():120207. PubMed ID: 35259554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Genetic Profiles and Prognosis of High-Grade Gliomas Using Quantitative and Qualitative MRI Features: A Focus on G3 Gliomas.
    Hong EK; Choi SH; Shin DJ; Jo SW; Yoo RE; Kang KM; Yun TJ; Kim JH; Sohn CH; Park SH; Won JK; Kim TM; Park CK; Kim IH; Lee ST
    Korean J Radiol; 2021 Feb; 22(2):233-242. PubMed ID: 32932560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic profiling reveals distinctive molecular relapse patterns in IDH1/2 wild-type glioblastoma.
    Riehmer V; Gietzelt J; Beyer U; Hentschel B; Westphal M; Schackert G; Sabel MC; Radlwimmer B; Pietsch T; Reifenberger G; Weller M; Weber RG; Loeffler M;
    Genes Chromosomes Cancer; 2014 Jul; 53(7):589-605. PubMed ID: 24706357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastoma.
    Stichel D; Ebrahimi A; Reuss D; Schrimpf D; Ono T; Shirahata M; Reifenberger G; Weller M; Hänggi D; Wick W; Herold-Mende C; Westphal M; Brandner S; Pfister SM; Capper D; Sahm F; von Deimling A
    Acta Neuropathol; 2018 Nov; 136(5):793-803. PubMed ID: 30187121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of TMEM59L associated with radiosensitive in glioblastoma.
    Gao D; Wang P; Zhi L; Sun S; Qiu X; Liu Y
    J Radiat Res; 2023 Sep; 64(5):833-841. PubMed ID: 37439405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in PlGF and MET-HGF expressions in paired initial and recurrent glioblastoma.
    Tabouret E; Denicolai E; Delfino C; Graillon T; Boucard C; Nanni I; Padovani L; Figarella-Branger D; Chinot O
    J Neurooncol; 2016 Dec; 130(3):431-437. PubMed ID: 27566180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TP53, ATRX alterations, and low tumor mutation load feature IDH-wildtype giant cell glioblastoma despite exceptional ultra-mutated tumors.
    Cantero D; Mollejo M; Sepúlveda JM; D'Haene N; Gutiérrez-Guamán MJ; Rodríguez de Lope Á; Fiaño C; Castresana JS; Lebrun L; Rey JA; Salmon I; Meléndez B; Hernández-Laín A
    Neurooncol Adv; 2020; 2(1):vdz059. PubMed ID: 32642724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of enzymes and oncogene induced after radiotherapy and/or chemotherapy in patients with brain tumors.
    Yoshii Y; Saito A; Hyodo A; Tsurushima H; Sun L
    Hum Cell; 2001 Mar; 14(1):95-103. PubMed ID: 11436358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic implications of epidermal and platelet-derived growth factor receptor alterations in 2 cohorts of IDH
    Alnahhas I; Rayi A; Guillermo Prieto Eibl MDP; Ong S; Giglio P; Puduvalli V
    Neurooncol Adv; 2021; 3(1):vdab127. PubMed ID: 34667950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted next-generation sequencing of adult gliomas for retrospective prognostic evaluation and up-front diagnostics.
    Petersen JK; Boldt HB; Sørensen MD; Blach S; Dahlrot RH; Hansen S; Burton M; Thomassen M; Kruse T; Poulsen FR; Andreasen L; Hager H; Ulhøi BP; Lukacova S; Reifenberger G; Kristensen BW
    Neuropathol Appl Neurobiol; 2021 Feb; 47(1):108-126. PubMed ID: 32696543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Farewell to GBM-O: Genomic and transcriptomic profiling of glioblastoma with oligodendroglioma component reveals distinct molecular subgroups.
    Hinrichs BH; Newman S; Appin CL; Dunn W; Cooper L; Pauly R; Kowalski J; Rossi MR; Brat DJ
    Acta Neuropathol Commun; 2016 Jan; 4():4. PubMed ID: 26757882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo Metabolic Profiles as Determined by
    Wenger KJ; Hattingen E; Franz K; Steinbach J; Bähr O; Pilatus U
    Clin Neuroradiol; 2019 Mar; 29(1):27-36. PubMed ID: 28983683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased intratumoral infiltration in IDH wild-type lower-grade gliomas observed with diffusion tensor imaging.
    Aliotta E; Batchala PP; Schiff D; Lopes BM; Druzgal JT; Mukherjee S; Patel SH
    J Neurooncol; 2019 Nov; 145(2):257-263. PubMed ID: 31531788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A tailored next-generation sequencing panel identified distinct subtypes of wildtype IDH and TERT promoter glioblastomas.
    Higa N; Akahane T; Yokoyama S; Yonezawa H; Uchida H; Takajo T; Kirishima M; Hamada T; Matsuo K; Fujio S; Hanada T; Hosoyama H; Yonenaga M; Sakamoto A; Hiraki T; Tanimoto A; Yoshimoto K
    Cancer Sci; 2020 Oct; 111(10):3902-3911. PubMed ID: 32748499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of a dedicated next generation sequencing panel for routine glioma diagnostics.
    Synhaeve NE; van den Bent MJ; French PJ; Dinjens WNM; Atmodimedjo PN; Kros JM; Verdijk R; Dirven CMF; Dubbink HJ
    Acta Neuropathol Commun; 2018 Nov; 6(1):126. PubMed ID: 30470264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent Glioblastomas Reveal Molecular Subtypes Associated with Mechanistic Implications of Drug-Resistance.
    Kwon SM; Kang SH; Park CK; Jung S; Park ES; Lee JS; Kim SH; Woo HG
    PLoS One; 2015; 10(10):e0140528. PubMed ID: 26466313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IDHwt glioblastomas can be stratified by their transcriptional response to standard treatment, with implications for targeted therapy.
    Tanner G; Barrow R; Ajaib S; Al-Jabri M; Ahmed N; Pollock S; Finetti M; Rippaus N; Bruns AF; Syed K; Poulter JA; Matthews L; Hughes T; Wilson E; Johnson C; Varn FS; Brüning-Richardson A; Hogg C; Droop A; Gusnanto A; Care MA; Cutillo L; Westhead DR; Short SC; Jenkinson MD; Brodbelt A; Chakrabarty A; Ismail A; Verhaak RGW; Stead LF
    Genome Biol; 2024 Feb; 25(1):45. PubMed ID: 38326875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A network model of a cooperative genetic landscape in brain tumors.
    Bredel M; Scholtens DM; Harsh GR; Bredel C; Chandler JP; Renfrow JJ; Yadav AK; Vogel H; Scheck AC; Tibshirani R; Sikic BI
    JAMA; 2009 Jul; 302(3):261-75. PubMed ID: 19602686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival impact of incidental subventricular zone irradiation in IDH-wildtype glioblastoma.
    Hallaert G; Pinson H; Van den Broecke C; Sweldens C; Van Roost D; Kalala JP; Boterberg T
    Acta Oncol; 2021 May; 60(5):613-619. PubMed ID: 33689536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical relevance of molecular subgrouping of gliomatosis cerebri per 2016 WHO classification: a clinicopathological study of 89 cases.
    Kwon MJ; Kang SY; Cho H; Lee JI; Kim ST; Suh YL
    Brain Pathol; 2020 Mar; 30(2):235-245. PubMed ID: 31435963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.